Peer review reports
From: A phase III randomized-controlled, single-blind trial to improve quality of life with stereotactic body radiotherapy for patients with painful bone metastases (ROBOMET)
Original Submission |
22 Jul 2019 |
Submitted |
Original manuscript
|
25 Aug 2019 |
Author responded |
Author comments - Carole Mercier
|
Resubmission - Version 2 |
25 Aug 2019 |
Submitted |
Manuscript version 2
|
Publishing |
26 Aug 2019 |
Editorially accepted |
|
4 Sep 2019 |
Article published |
10.1186/s12885-019-6097-z
|
Learn about peer review